OncoCyte Corporation and The Wistar Institute Enter Into Global Licensing Agreement ALAMEDA, Calif. and PHILADELPHIA, Jan. 27, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood based tests for the early detection of cancer, and...

OncoCyte Corporation Initiates Trading on the NYSE MKT Company’s Common Stock Listed Under the Symbol “OCX” beginning January 4, 2016 The Company Will Publish an Introductory Investor Webcast January 5, 2016 at 4 p.m. ET OncoCyte Scheduled to Ring the...